Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 179
Filter
1.
Dermatol Online J ; 25(9)2019 Sep 15.
Article in English | MEDLINE | ID: mdl-31738843

ABSTRACT

Candida is a genus of yeasts that can be a part of normal human skin flora, but may cause disease when the skin barrier is compromised. C. albicans is the most common pathogenic species of this genus, but in recent years infection with other species, such as C. parapsilosis has been growing. C. parapsilosis is a species of Candida that has been found in the skin of humans and other mammals, including dogs. In this brief report, the authors describe two cases of atypical periorifical infection with C. parapsilosis in patients who both volunteered in dog shelters. Owing to the atypical presentation of the fungal infections, the isolation of C. parapsilosis as the causative organism and their extensive history of exposure to dogs, these cases may represent the first evidence of possible zoonotic transmission of C. parapsilosis from dogs to humans.


Subject(s)
Candida parapsilosis/isolation & purification , Candidiasis, Cutaneous/transmission , Dog Diseases/transmission , Zoonoses/transmission , Adult , Aged, 80 and over , Animals , Candidiasis, Cutaneous/pathology , Dogs , Face/pathology , Female , Humans
3.
J Am Acad Dermatol ; 80(4): 869-880.e5, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30102951

ABSTRACT

Angioinvasive fungal infections cause significant morbidity and mortality because of their propensity to invade blood vessel walls, resulting in catastrophic tissue ischemia, infarct, and necrosis. While occasionally seen in immunocompetent hosts, opportunistic fungi are emerging in immunosuppressed hosts, including patients with hematologic malignancy, AIDS, organ transplant, and poorly controlled diabetes mellitus. The widespread use of antifungal prophylaxis has led to an "arms race" of emerging fungal resistance patterns. As the at-risk population expands and new antifungal resistance patterns develop, it is critical for dermatologists to understand and recognize angioinvasive fungal pathogens, because they are often the first to encounter the cutaneous manifestations of these diseases. Rapid clinical recognition, histopathologic, and culture confirmation can help render a timely, accurate diagnosis to ensure immediate medical and surgical intervention. Superficial dermatophyte infections and deep fungal infections, such as blastomycosis and histoplasmosis, have been well characterized within the dermatologic literature, and therefore this article will focus on the severe infections acquired by angioinvasive fungal species, including an update on new and emerging pathogens. In the first article in this continuing medical education series, we review the epidemiology and cutaneous manifestations. The second article in the series focuses on diagnosis, treatment, and complications of these infections.


Subject(s)
Dermatomycoses/pathology , Skin/blood supply , Aspergillosis/complications , Aspergillosis/diagnosis , Aspergillosis/epidemiology , Aspergillosis/pathology , Blood Vessels/pathology , Candidiasis, Cutaneous/complications , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/epidemiology , Candidiasis, Cutaneous/pathology , Dermatomycoses/complications , Dermatomycoses/diagnosis , Dermatomycoses/epidemiology , Drug Resistance, Fungal , Humans , Mucormycosis/complications , Mucormycosis/diagnosis , Mucormycosis/epidemiology , Mucormycosis/pathology , Opportunistic Infections/complications , Opportunistic Infections/diagnosis , Opportunistic Infections/epidemiology , Opportunistic Infections/pathology , Phaeohyphomycosis/complications , Phaeohyphomycosis/diagnosis , Phaeohyphomycosis/epidemiology , Phaeohyphomycosis/pathology
6.
J Dermatol ; 44(7): 760-766, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28225185

ABSTRACT

The objective of the present randomized, double-blind trial was to evaluate the efficacy and safety of daily washing with miconazole nitrate-containing soap for candidiasis at diaper-covered sites in elderly subjects under long-term inpatient care. To confirm the onset and disappearance of candidiasis, we microscopically evaluated the existence of the pseudohyphae and/or blastoconidia of Candida spp. We enrolled 75 elderly patients who wore diapers all day in the hospital or nursing home. Patients were randomly assigned to receive treatment with either miconazole soap or miconazole-free placebo soap, and 28 patients in the miconazole group and 27 patients in the placebo group were followed for 4 weeks. Although washing with miconazole soap did not affect the frequency of pseudohyphae/blastoconidia-positive patients, it significantly inhibited the positive conversion of pseudohyphae/blastoconidia compared with the placebo group. As a result, the frequency of patients positive for pseudohyphae/blastoconidia was significantly lower in the miconazole group than in the control group at 4 weeks (17.9% vs 44.4%). Clinically apparent diaper candidiasis did not develop in either group. Washing with miconazole soap was a significant independent factor for reducing the cases positive for pseudohyphae/blastoconidia, while diarrhea and heart failure were significant factors associated with an increase in the positive rate at the end-point. Severe adverse effects were not found in any patients. Thus, washing with miconazole soap is well-tolerated and can inhibit the positive conversion of Candida in patients wearing diapers. Therefore, maintenance of genital hygiene using this soap may prophylactically decrease the overall prevalence of patients with diaper candidiasis.


Subject(s)
Antifungal Agents/therapeutic use , Candida/drug effects , Candidiasis, Cutaneous/prevention & control , Diaper Rash/prevention & control , Miconazole/therapeutic use , Soaps/therapeutic use , Aged , Aged, 80 and over , Candida/isolation & purification , Candida/physiology , Candidiasis, Cutaneous/epidemiology , Candidiasis, Cutaneous/microbiology , Candidiasis, Cutaneous/pathology , Diaper Rash/epidemiology , Diaper Rash/microbiology , Diaper Rash/pathology , Double-Blind Method , Female , Genitalia/microbiology , Genitalia/pathology , Humans , Hygiene , Hyphae/drug effects , Hyphae/isolation & purification , Japan , Male , Microscopy , Prevalence , Prospective Studies , Skin/microbiology , Skin/pathology , Soaps/chemistry , Spores, Fungal/drug effects , Spores, Fungal/isolation & purification , Treatment Outcome
7.
Mycopathologia ; 182(3-4): 409-412, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27807668

ABSTRACT

Fournier gangrene is a rare, rapidly progressive, life-threatening condition. We report a 23-day-old boy with pulmonary atresia and ventricular septal defect treated surgically, who developed Fournier gangrene. Emergency surgery was performed with tissue sampling for microbiological examination. Candida albicans was confirmed; caspofungin followed by fluconazole was administered with excellent results.


Subject(s)
Candida albicans/isolation & purification , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/pathology , Fournier Gangrene/etiology , Fournier Gangrene/pathology , Scrotum/pathology , Antifungal Agents/therapeutic use , Candidiasis, Cutaneous/drug therapy , Candidiasis, Cutaneous/microbiology , Caspofungin , Echinocandins/therapeutic use , Fluconazole/therapeutic use , Fournier Gangrene/drug therapy , Humans , Infant, Newborn , Lipopeptides/therapeutic use , Male , Scrotum/microbiology , Thoracic Surgery , Treatment Outcome
8.
J Biol Regul Homeost Agents ; 30(2 Suppl 3): 89-93, 2016.
Article in English | MEDLINE | ID: mdl-27498664

ABSTRACT

Candidal intertrigo is an infection of the skin caused by Candida albicans that typically occurs in opposing cutaneous or muco-cutaneous surfaces. Because Candidiasis requires a damaged and moist environment for infection, it typically occurs in areas of friction such as the skin folds of the body. Candidal intertrigo is often difficult to treat and results are often unsatisfactory. In addition, there is a lack of evidence-based literature supporting prevention and treatments for candidal intertrigo. The aim of the study was to evaluate the efficacy of Dr Michaels® (also branded as Fungatinex®) products in the treatment of fungal intertrigo, in 20 women and 2 men with a mean age of 72. Five patients (3 female and 2 male) had type 2 diabetes and 16 (14 female and 2 male) were obese. The patients were treated with Dr Michaels® (Fungatinex®) moisturising bar, topical ointment (twice daily application) and oral herbal formulation, PSC 200 two tablets twice daily with food. After 2 weeks of treatment, the lesions had mostly resolved in all patients with only slight erythema evident. After six weeks of treatment using the moisturising bar, topical ointment and oral herbal formulations from the Dr Michaels® (Fungatinex®) product family, the lesions had totally resolved in 18 patients, while 4 patients had to continue the therapeutic protocol for another 2 weeks. Our results demonstrate that the Dr Michaels® (Fungatinex®) complementary product family is efficacious in the treatment of recalcitrant candidal intertrigo. Furthermore, this study highlights that the Dr Michaels® (Fungatinex®) product family is fast-acting and well tolerated with no serious adverse events reported. These data have important implications for resistant cases of candidal intertrigo where traditional therapies have failed.


Subject(s)
Candidiasis, Cutaneous/drug therapy , Intertrigo/drug therapy , Ointments/therapeutic use , Phytotherapy , Administration, Cutaneous , Aged , Candidiasis, Cutaneous/complications , Candidiasis, Cutaneous/pathology , Complementary Therapies/methods , Diabetes Mellitus, Type 2/complications , Female , Humans , Intertrigo/complications , Intertrigo/pathology , Male , Obesity/complications , Ointments/administration & dosage , Skin/drug effects , Skin/pathology , Skin Care/methods
9.
Dermatol Online J ; 21(11)2015 Nov 18.
Article in English | MEDLINE | ID: mdl-26632935

ABSTRACT

Candida krusei (C. krusei) is a multidrug-resistant opportunistic fungal pathogen that may cause disseminated infections in immunocompromised hosts. However, its clinical and histologic features are not well-characterized. We present a unique case to contribute to the growing knowledge base associated with this organism. During hospitalization for neutropenic fever, a 19-year-old man with acute myeloid leukemia, who underwent hematopoietic stem cell transplantation, developed a generalized folliculocentric eruption following initiation of antifungal therapy for newly diagnosed C. krusei fungemia. Despite adequate antifungal coverage and negative blood cultures, the follicular-based erythematous papules persisted. Biopsies demonstrated yeast within ruptured follicles, without angiotropism or involvement of the interfollicular dermis, subcutaneous tissue, or stratum corneum. Concurrent skin tissue cultures confirmed C. krusei. The patient remained febrile despite aggressive antifungal therapy, with relapse of leukemia and subsequent death. Our case is unusual given the development of cutaneous lesions following clearance of fungemia, with yeast limited to ruptured follicular lumina, possibly indicating a primary cutaneous source or early transfollicular/transepidermal elimination. Given the limited available descriptions of cutaneous histopathology for C. krusei, we seek to add to the understanding of its pathophysiology and aid in the diagnosis and treatment of this often fatal infection.


Subject(s)
Candidiasis, Cutaneous/drug therapy , Candidiasis, Cutaneous/pathology , Candidiasis/drug therapy , Candidiasis/pathology , Antifungal Agents/therapeutic use , Candidiasis/immunology , Candidiasis, Cutaneous/immunology , Fatal Outcome , Fungemia/drug therapy , Fungemia/immunology , Fungemia/pathology , Humans , Immunocompromised Host , Leukemia, Myeloid, Acute/complications , Male , Young Adult
10.
J Am Acad Dermatol ; 73(3): 367-81; quiz 381-2, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26282795

ABSTRACT

Several primary immunodeficiencies (PIDs) have recently been described that confer an elevated risk of fungal infections and noninfectious cutaneous manifestations. In addition, immunologic advances have provided new insights into our understanding of the pathophysiology of fungal infections in established PIDs. We reviewed PIDs that present with an eczematous dermatitis in part I. In part II of this continuing medical education article we discuss updates on PIDs associated with fungal infections, their biologic basis in PIDs, and noninfectious cutaneous manifestations.


Subject(s)
Candidiasis, Cutaneous/epidemiology , Candidiasis, Cutaneous/pathology , Eczema/epidemiology , Eczema/pathology , Immunologic Deficiency Syndromes/epidemiology , Immunologic Deficiency Syndromes/pathology , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/therapy , Comorbidity , Eczema/diagnosis , Eczema/therapy , Education, Medical, Continuing , Female , Follow-Up Studies , Humans , Immunologic Deficiency Syndromes/diagnosis , Immunologic Deficiency Syndromes/therapy , Incidence , Male , Molecular Targeted Therapy/methods , Severity of Illness Index
11.
J Med Microbiol ; 64(8): 810-817, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26271575

ABSTRACT

Chronic mucocutaneous candidiasis constitutes a heterogeneous group of syndromes, characterized by non-invasive infection of the skin, nails and mucosal membranes by the fungus Candida spp. Although symptoms are heterogeneous, in all cases there is a reduction in protective cytokines, favouring the development of disease. The normal role of cytokines in skin lesions is not well understood. The present study aimed to investigate the progression of disease, understand specific cellular and molecular components involved in immunity to Candida albicans and determine the balance between pro- and anti-inflammatory cytokines over the course of cutaneous infection in immunocompetent mice. BALB/c mice (five per group) were inoculated with 5 × 10(6)C. albicans pseudohyphae in the deep dermis of the paw and analysed over 1-14  days post-infection. The contralateral paws were used for negative controls. Haematoxylin and eosin staining of skin sections during C. albicans infection was performed to analyse structural modifications to the epidermis such as hyperplasia, and infiltration of neutrophils and fibroblasts in the dermis. The cytokine populations were determined by capture ELISA using popliteal lymph node tissue. Pro-inflammatory cytokines (IL-6, TNF-α, IL-12, IFN-γ and IL-17) were detected at significant levels during the initial phase of cutaneous infection and correlated with the rapid elimination of C. albicans. Anti-inflammatory cytokines (IL-13, IL-4, IL-10 and transforming growth factor-ß) were detected on day 4 post-infection, and prevented exacerbation of inflammation and participated in healing of lesions. Thus, a balance between pro- and anti-inflammatory cytokines was fundamental for the resolution of infection. Importantly, these findings broaden our understanding of the immune mechanisms involved in chronic cutaneous candidiasis.


Subject(s)
Candida albicans/growth & development , Candida albicans/immunology , Candidiasis, Cutaneous/immunology , Candidiasis, Cutaneous/pathology , Skin/immunology , Skin/pathology , Animals , Cytokines/analysis , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Female , Histocytochemistry , Lymph Nodes/immunology , Mice, Inbred BALB C , Microscopy , Neutrophils/immunology
12.
Emerg Infect Dis ; 21(8): 1462-5, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26197035

ABSTRACT

The prevalence of Candidatus Neoehrlichia mikurensis infection was determined in 102 persons bitten by ticks in Sweden. Two infected women had erythematous rashes; 1 was co-infected with a Borrelia sp., and the other showed seroconversion for Anaplasma phagocytophilum. Both patients had increased levels of Neoehrlichia DNA and serum cytokines for several months.


Subject(s)
Candidiasis, Cutaneous/diagnosis , Cytokines/metabolism , DNA, Bacterial/genetics , Tick-Borne Diseases/diagnosis , Ticks , Aged , Animals , Candidiasis, Cutaneous/pathology , Coinfection/complications , Female , Humans , Middle Aged , Sweden
13.
PLoS One ; 10(4): e0122807, 2015.
Article in English | MEDLINE | ID: mdl-25849644

ABSTRACT

Candida albicans is a commensal fungal microbe of the human orogastrointestinal tract and skin. C. albicans causes multiple forms of disease in immunocompromised patients, including oral, vaginal, dermal and disseminated candidiasis. The cytokine IL-17 (IL-17A) and its receptor subunits, IL-17RA and IL-17RC, are required for protection to most forms of candidiasis. The importance of the IL-17R pathway has been observed not only in knockout mouse models, but also in humans with rare genetic mutations that impact generation of Th17 cells or the IL-17 signaling pathway, including Hyper-IgE Syndrome (STAT3 or TYK2 mutations) or IL17RA or ACT1 gene deficiency. The IL-17 family of cytokines is a distinct subclass of cytokines with unique structural and signaling properties. IL-17A is the best-characterized member of the IL-17 family to date, but far less is known about other IL-17-related cytokines. In this study, we sought to determine the role of a related IL-17 cytokine, IL-17C, in protection against oral, dermal and disseminated forms of C. albicans infection. IL-17C signals through a heterodimeric receptor composed of the IL-17RA and IL-17RE subunits. We observed that IL-17C mRNA was induced following oral C. albicans infection. However, mice lacking IL-17C or IL-17RE cleared C. albicans infections in the oral mucosa, skin and bloodstream at rates similar to WT littermate controls. Moreover, these mice demonstrated similar gene transcription profiles and recovery kinetics as WT animals. These findings indicate that IL-17C and IL-17RE are dispensable for immunity to the forms of candidiasis evaluated, and illustrate a surprisingly limited specificity of the IL-17 family of cytokines with respect to systemic, oral and cutaneous Candida infections.


Subject(s)
Candidiasis/immunology , Candidiasis/pathology , Interleukin-17/metabolism , Protein Subunits/metabolism , Receptors, Interleukin-17/metabolism , Signal Transduction/immunology , Animals , Candidiasis/metabolism , Candidiasis, Cutaneous/immunology , Candidiasis, Cutaneous/metabolism , Candidiasis, Cutaneous/pathology , Candidiasis, Oral/immunology , Candidiasis, Oral/metabolism , Candidiasis, Oral/pathology , Disease Resistance , Female , Interleukin-17/deficiency , Male , Mice , Mice, Inbred C57BL , Protein Subunits/deficiency , Receptors, Interleukin-17/deficiency
14.
16.
Cutis ; 93(4): 204-6, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24818181

ABSTRACT

We report the case of a 61-year-old man with diffuse large B-cell lymphoma who presented with a tender skin lesion on the left side of the flank of 5 weeks' duration after undergoing myeloablative chemotherapy. Prior treatment with intravenous vancomycin showed minimal response. Clinical examination revealed a tender, indurated, erythematous plaque on the left side of the flank. A skin biopsy demonstrated a lymphohistiocytic and neutrophilic infiltrate with deep dermal necrosis and fungal forms in the dermis and subcutis. A tissue culture grew Candida tropicalis; however, blood cultures remained negative for yeast. A diagnosis of primary cutaneous candidiasis was made based on the lack of response to antibiotics, tissue evidence of C tropicalis, and negative blood cultures. Although rare, primary cutaneous candidiasis should be considered in immunocompromised patients presenting with cellulitis or an abscess that is unresponsive to treatment.


Subject(s)
Candida tropicalis/isolation & purification , Candidiasis, Cutaneous/etiology , Immunocompromised Host , Lymphoma, Large B-Cell, Diffuse/pathology , Biopsy , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/pathology , Cellulitis/diagnosis , Diagnosis, Differential , Humans , Male , Middle Aged
20.
Biomedica ; 32(2): 170-3, 2012 Jun.
Article in Spanish | MEDLINE | ID: mdl-23242288

ABSTRACT

INTRODUCTION: Cutaneous candidiasis is a disease that affects children as well as adults. The presentation may be localized or systemic, and with multiple etiological agents. The most prevalent infecting species in children differs from that of the adult. OBJECTIVE: A case is presented where a congenital cutaneous candidiasis was transmitted to the child during birth. MATERIALS AND METHODS: A full term newborn was exposed to a subclinical vaginal candidiasis infection, and 24 hr after birth, developed congenital cutaneous candidiasis. The etiological agent was Candida albicans, and was associated with sepsis and respiratory distress. Blood cultures, cutaneous biopsy of vesicular lesions, blood tests and lumbar puncture were performed. RESULTS: Biochemistry and blood count showed a CRP of 5.7 mg/dl, leukocytosis with left shift and mild anemia. After 24 hr, the blood analyses showed an increase in a CRP (7.8 mg/dl) and increased progressively for three days; consequently, a lumbar puncture was performed. Blood culture was positive for Staphylococcus aureus. Cutaneous biopsy confirmed the cutaneous candidiasis. CONCLUSIONS: The early diagnosis is essential to prevent complications derived by the Candida albicans in newborns.


Subject(s)
Candidiasis, Cutaneous/congenital , Infectious Disease Transmission, Vertical , Administration, Cutaneous , Administration, Oral , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/therapeutic use , Bacteremia/complications , Bacteremia/drug therapy , Bacteremia/microbiology , Bicarbonates/administration & dosage , Bicarbonates/therapeutic use , Candidiasis, Cutaneous/complications , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/drug therapy , Candidiasis, Cutaneous/pathology , Candidiasis, Cutaneous/transmission , Candidiasis, Vulvovaginal/transmission , Cefotaxime/administration & dosage , Cefotaxime/therapeutic use , Cerebrospinal Fluid/microbiology , Chlorhexidine/therapeutic use , Coinfection , Early Diagnosis , Emollients/administration & dosage , Emollients/therapeutic use , Female , Humans , Infant, Newborn , Male , Miconazole/administration & dosage , Miconazole/therapeutic use , Potassium Permanganate/administration & dosage , Potassium Permanganate/therapeutic use , Pregnancy , Pregnancy Complications, Infectious , Respiration Disorders/etiology , Sepsis/etiology , Staphylococcal Infections/complications , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification , Therapeutic Irrigation
SELECTION OF CITATIONS
SEARCH DETAIL